Chen et al. showed, based on K‒M curves, that GSDMB and CASP6 are associated with better prognoses for patients with BCa [70]; they also found that many tumours with high GSDMB and CASP6 expression were immune-inflamed tumours and that many tumours with low GSDMB and CASP6 expression were immune-desert tumours. Here, CASP6 is linked to neoplasm.